Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs

Oligonucleotides

Volumn 18, Issue 2, 2008, Pages 187-200

  Collingwood, Michael A ^a   Rose, Scott D ^a   Huang, Lingyan ^a   Hillier, Chris ^a   Amarzguioui, Mohammad ^b,c   Wiiger, Merete T ^b   Soifer, Harris S ^d   Rossi, John J ^d   Behlke, Mark A ^a  

^a INTEGRATED DNA TECHNOLOGIES   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c SiRNAsense AS   (Norway)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; DICER SUBSTRATE SMALL INTERFERING RNA; SMALL INTERFERING RNA;

ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG POTENCY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; PRIORITY JOURNAL; RNA INTERFERENCE; RNA SEQUENCE; RNA SYNTHESIS; SERUM;

BASE SEQUENCE; CELLS, CULTURED; DEAD-BOX RNA HELICASES; ENDORIBONUCLEASES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HCT116 CELLS; HELA CELLS; HUMANS; INTERFERON-ALPHA; KINETICS; LEUKOCYTES, MONONUCLEAR; LUCIFERASES, RENILLA; MOLECULAR SEQUENCE DATA; PLASMIDS; REFERENCE STANDARDS; RNA; RNA INTERFERENCE; RNA, DOUBLE-STRANDED; RNA, SMALL INTERFERING; SENSITIVITY AND SPECIFICITY; SUBSTRATE SPECIFICITY; TRANSFECTION;

EID: 47649095102     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2008.0123     Document Type: Article

References (47)

1. ALLERSON, C.R., SIOUFI, N., JARRES, R., PRAKASH, T.P., NAIK, N., BERDEJA, A., WANDERS, L., GRIFFEY, R.H., SWAYZE, E.E., and BHAT, B. (2005). Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J. Med. Chem. 48, 901-904.
2. AMARZGUIOUI, M., HOLEN, T., BABAIE, E., and PRYDZ, H. (2003). Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 31, 589-595.
3. BEHLKE, M.A. (2006). Progress towards in vivo use of siRNAs. Mol. Ther. 13, 644-670.
4. BERNSTEIN, E., CAUDY, A.A., HAMMOND, S.M., and HANNON, G.J. (2001). Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366.
5. BIECHE, I., NOGUES, C., PARADIS, V., OLIVI, M., BEDOSSA, P., LIDEREAU, R., and VIDAUD, M. (2000). Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin. Cancer Res. 6, 452-459.
6. BRAASCH, D.A., JENSEN, S., LIU, Y., KAUR, K., ARAR, K., WHITE, M.A., and COREY, D.R. (2003). RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42, 7967-7975.
7. CHIU, Y.L., and RANA, T.M. (2003). siRNA function in RNAi: a chemical modification analysis. RNA 9, 1034-1048.
8. CHOUNG, S., KIM, Y.J., KIM, S., PARK, H.O., and CHOI, Y.C. (2006). Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem. Biophys. Res. Commun. 342, 919-927.
9. CZAUDERNA, F., FECHTNER, M., DAMES, S., AYGUN, H., KLIPPEL, A., PRONK, G.J., GIESE, K., and KAUFMANN, J. (2003). Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31, 2705-2716.
10. EDER, P.S., DEVINE, R.J., DAGLE, J.M., and WALDER, J.A. (1991). Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3′ exonuclease in plasma. Antisense Res. Dev. 1, 141-151.
11. EGLI, M., MINASOV, G., TERESHKO, V., PALLAN, P.S., TEPLOVA, M., INAMATI, G.B., LESNIK, E.A., OWENS, S.R., ROSS, B.S., PRAKASH, T.P., and MANOHARAN, M. (2005). Probing the influence of stereoelectronic effects on the biophysical properties of oligonucleotides: comprehensive analysis of the RNA affinity, nuclease resistance, and crystal structure of ten 2′-O-ribonucleic acid modifications. Biochemistry 44, 9045-9057.
12. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
13. ELMEN, J., THONBERG, H., LJUNGBERG, K., FRIEDEN, M., WESTERGAARD, M., XU, Y., WAHREN, B., LIANG, Z., ORUM, H., KOCH, T., and WAHLESTEDT, C. (2005). Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 33, 439-447.
14. FREIER, S.M., and ALTMANN, K.H. (1997). The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexes. Nucleic Acids Res. 25, 4429-4443.
15. GRUNWELLER, A., WYSZKO, E., BIEBER, B., JAHNEL, R., ERDMANN, V.A., and KURRECK, J. (2003). Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31, 3185-3193.
16. HAIL, M.E., ELLIOTT, B., and ANDERSON, K. (2004). High-throughput analysis of oligonucleotides using automated electrospray ionization mass spectrometry. Am. Biotechnol. Lab. 12, 12-14.
17. HALL, A.H., WAN, J., SHAUGHNESSY, E.E., RAMSAY SHAW, B., and ALEXANDER, K.A. (2004). RNA interference using boranophosphate siRNAs: structure-activity relationships. Nucleic Acids Res. 32, 5991-6000.
18. HALL, A.H., WAN, J., SPESOCK, A., SERGUEEVA, Z., SHAW, B.R., and ALEXANDER, K.A. (2006). High potency silencing by single-stranded boranophosphate siRNA. Nucleic Acids Res. 34, 2773-2781.
19. HANNON, G.J., and ROSSI, J.J. (2004). Unlocking the potential of the human genome with RNA interference. Nature 431, 371-378.
20. HARBORTH, J., ELBASHIR, S.M., VANDENBURGH, K., MANNINGA, H., SCARINGE, S.A., WEBER, K., and TUSCHL, T. (2003). Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13, 83-105.
21. HEIDEL, J.D., HU, S., LIU, X.F., TRICHE, T.J., and DAVIS, M.E. (2004). Lack of interferon response in animals to naked siRNAs. Nat. Biotechnol. 22, 1579-1582.
22. HEIL, F., HEMMI, H., HOCHREIN, H., AMPENBERGER, F., KIRSCHNING, C., AKIRA, S., LIPFORD, G., WAGNER, H., and BAUER, S. (2004). Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529.
23. HORNUNG, V., GUENTHNER-BILLER, M., BOURQUIN, C., ABLASSER, A., SCHLEE, M., UEMATSU, S., NORONHA, A., MANOHARAN, M., AKIRA, S., DE FOUGEROLLES, A., ENDRES, S., and HARTMANN, G. (2005). Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263-270.
24. JUDGE, A.D., BOLA, G., LEE, A.C., and MACLACHLAN, I. (2006). Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13, 494-505.
25. KARIKO, K., BUCKSTEIN, M., NI, H., and WEISSMAN, D. (2005). Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165-175.
26. KIM, D.H., BEHLKE, M.A., ROSE, S.D., CHANG, M.S., CHOI, S., and ROSSI, J.J. (2005). Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23, 222-226.
27. KRAYNACK, B.A., and BAKER, B.F. (2006). Small interfering RNAs containing full 2′-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity. RNA 12, 163-176.
28. KUBO, T., ZHELEV, Z., OHBA, H., and BAKALOVA, R. (2007). Modified 27-nt dsRNAs with dramatically enhanced stability in serum and long-term RNAi activity. Oligonucleotides 17, 445-464.
29. KURRECK, J. (2003). Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 270, 1628-1644.
30. MARQUES, J.T., DEVOSSE, T., WANG, D., ZAMANIAN-DARYOUSH, M., SERBINOWSKI, P., HARTMANN, R., FUJITA, T., BEHLKE, M.A., and WILLIAMS, B.R. (2006). A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24, 559-565.
31. MARQUES, J.T., and WILLIAMS, B.R. (2005). Activation of the mammalian immune system by siRNAs. Nat. Biotechnol. 23, 1399-1405.
32. MEISTER, G., and TUSCHL, T. (2004). Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343-349.
33. MOOK, O.R., BAAS, F., DE WISSEL, M.B., and FLUITER, K. (2007). Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo. Mol. Cancer Ther. 6, 833-843.
34. MORRISSEY, D.V., BLANCHARD, K., SHAW, L., JENSEN, K., LOCKRIDGE, J.A., DICKINSON, B., MCSWIGGEN, J.A., VARGEESE, C., BOWMAN, K., SHAFFER, C.S., POLISKY, B.A., and ZINNEN, S. (2005a). Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41, 1349-1356.
35. MORRISSEY, D.V., LOCKRIDGE, J.A., SHAW, L., BLANCHARD, K., JENSEN, K., BREEN, W., HARTSOUGH, K., MACHEMER, L., RADKA, S., JADHAV, V., VAISH, N., ZINNEN, S., VARGEESE, C., BOWMAN, K., SHAFFER, C.S., JEFFS, L.B., JUDGE, A., MACLACHLAN, I., and POLISKY, B. (2005b). Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23, 1002-1007.
36. NAWROT, B., and SIPA, K. (2006). Chemical and structural diversity of siRNA molecules. Curr. Top. Med. Chem. 6, 913-925.
37. PEEK, A.S. (2007). Improving model predictions for RNA interference activities that use support vector machine regression by combining and filtering features. BMC Bioinformatics 8, 182.
38. PEEK, A.S., and BEHLKE, M.A. (2007). Design of active small interfering RNAs. Curr. Opin. Mol. Ther. 9, 110-118.
39. PRAKASH, T.P., ALLERSON, C.R., DANDE, P., VICKERS, T.A., SIOUFI, N., JARRES, R., BAKER, B.F., SWAYZE, E.E., GRIFFEY, R.H., and BHAT, B. (2005). Positional effect of chemical modifications on short interference RNA activity in mammalian cells. J. Med. Chem. 48, 4247-4253.
40. REYNOLDS, A., ANDERSON, E.M., VERMEULEN, A., FEDOROV, Y., ROBINSON, K., LEAKE, D., KARPILOW, J., MARSHALL, W.S., and KHVOROVA, A. (2006). Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 12, 988-993.
41. ROBBINS, M., JUDGE, A., LIANG, L., MCCLINTOCK, K., YAWORSKI, E., and MACLACHLAN, I. (2007). 2′-O-methyl-modified RNAs act as TLR7 antagonists. Mol. Ther. 15, 1663-1669.
42. ROSE, S.D., KIM, D.H., AMARZGUIOUI, M., HEIDEL, J.D., COLLINGWOOD, M.A., DAVIS, M.E., ROSSI, J.J., and BEHLKE, M.A. (2005). Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids Res. 33, 4140-4156.
43. SCHLEE, M., HORNUNG, V., and HARTMANN, G. (2006). siRNA and isRNA: two edges of one sword. Mol. Ther. 14, 463-470.
44. SIOUD, M. (2005). Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348, 1079-1090.
45. STEEN, A.M., SAHLEN, S., and LAMBERT, B. (1991). Expression of the hypoxanthine phosphoribosyl transferase gene in resting and growth-stimulated human lymphocytes. Biochim. Biophys. Acta 1088, 77-85.
46. ZAMANIAN-DARYOUSH, M., MARQUES, J.T., GANTIER, M.P., BEHLKE, M.A., JOHN, M., RAYMAN, P., FINKE, J., and WILLIAMS, B.R. (2008). Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells. J. Interferon Cytokine Res. 28, 221-233.
47. ZHANG, H.Y., DU, Q., WAHLESTEDT, C., and LIANG, Z. (2006). RNA Interference with chemically modified siRNA. Curr. Top. Med. Chem. 6, 893-900.